Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam M Brufsky

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Seminars in Oncology|August 5, 2010
The evolving role of bone-conserving therapy in patients with breast cancerAdam M Brufsky
Breast Cancer : Basic and Clinical Research|August 16, 2014
Current Approaches and Emerging Directions in HER2-resistant Breast CancerAdam M Brufsky
Expert Opinion on Pharmacotherapy|April 2, 2008
Zoledronic acid for cancer therapy--induced and postmenopausal bone lossAdam M Brufsky
Clinical Medicine Insights. Oncology|January 22, 2016
Delaying Chemotherapy in the Treatment of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerAdam M Brufsky
Clinical Breast Cancer|February 20, 2008
Managing bone loss in women with early-stage breast cancer receiving aromatase inhibitorsAdam M Brufsky
Current Oncology Reports|March 28, 2008
Bone health issues in women with early-stage breast cancer receiving aromatase inhibitorsAdam M Brufsky
The Breast Journal|May 28, 2014
Managing postmenopausal women with hormone receptor-positive advanced breast cancer who progress on endocrine therapies with inhibitors of the PI3K pathwayAdam M Brufsky
Oncology (Williston Park, N.Y.)|July 17, 2015
Some Excitement, Some DisappointmentAdam M Brufsky
Cancer Treatment Reviews|July 19, 2017
Long-term management of patients with hormone receptor-positive metastatic breast cancer: Concepts for sequential and combination endocrine-based therapiesAdam M Brufsky
The Oncologist|February 29, 2008
Cancer treatment-induced bone loss: pathophysiology and clinical perspectivesAdam M Brufsky
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Seminars in Oncology|August 5, 2010
The evolving role of bone-conserving therapy in patients with breast cancerAdam M Brufsky
Breast Cancer : Basic and Clinical Research|August 16, 2014
Current Approaches and Emerging Directions in HER2-resistant Breast CancerAdam M Brufsky
Expert Opinion on Pharmacotherapy|April 2, 2008
Zoledronic acid for cancer therapy--induced and postmenopausal bone lossAdam M Brufsky
Clinical Medicine Insights. Oncology|January 22, 2016
Delaying Chemotherapy in the Treatment of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerAdam M Brufsky
Clinical Breast Cancer|February 20, 2008
Managing bone loss in women with early-stage breast cancer receiving aromatase inhibitorsAdam M Brufsky
Current Oncology Reports|March 28, 2008
Bone health issues in women with early-stage breast cancer receiving aromatase inhibitorsAdam M Brufsky
The Breast Journal|May 28, 2014
Managing postmenopausal women with hormone receptor-positive advanced breast cancer who progress on endocrine therapies with inhibitors of the PI3K pathwayAdam M Brufsky
Oncology (Williston Park, N.Y.)|July 17, 2015
Some Excitement, Some DisappointmentAdam M Brufsky
Cancer Treatment Reviews|July 19, 2017
Long-term management of patients with hormone receptor-positive metastatic breast cancer: Concepts for sequential and combination endocrine-based therapiesAdam M Brufsky
The Oncologist|February 29, 2008
Cancer treatment-induced bone loss: pathophysiology and clinical perspectivesAdam M Brufsky
Pageof 19